Table 1: Clinical characteristics of patients.
|
BC n 21 (%) |
T+ n 8 (%) |
no BC n 9 (%) |
|
|
Gender |
|||
|
M |
12(57) |
7(87) |
7(77) |
|
F |
9(43) |
1(13) |
2(23) |
|
Smoking |
|||
|
No |
11(52) |
1(13) |
9(100) |
|
Yes |
10(48) |
7(87) |
0 |
|
Stage |
|||
|
Ta |
13(61) |
4(50) |
0 |
|
T1 |
8(39) |
4(50) |
0 |
|
T2 |
0 |
0 |
0 |
|
PUNLMP |
0 |
0 |
0 |
|
CIS |
0 |
0 |
0 |
|
Grade |
|||
|
LG |
7(33) |
4(50) |
0 |
|
HG |
14(66) |
4(50) |
0 |
|
Multiplicity |
|||
|
Solitary |
4(19) |
6(75) |
0 |
|
Multiple |
2(6) |
2(25) |
0 |
|
Unclear |
15(75) |
0 |
0 |
BC cases with previously diagnosed, removed, but not recently confirmed tumors; T+ cases with tumor confirmed within 6 months of DNA analysis; no BC- control subjects.